Phase I Trial to Assess the Safety and Pharmacokinetics of a Single Ascending Dose (SAD) of N-Methanocarbathymidine (N-MCT) in Normal Volunteers

Trial Profile

Phase I Trial to Assess the Safety and Pharmacokinetics of a Single Ascending Dose (SAD) of N-Methanocarbathymidine (N-MCT) in Normal Volunteers

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 29 Sep 2016

At a glance

  • Drugs N Methanocarbathymidine (Primary)
  • Indications Herpes zoster
  • Focus Adverse reactions
  • Sponsors N&N Pharmaceuticals
  • Most Recent Events

    • 21 Sep 2016 Planned primary completion date changed from 1 Aug 2016 to 1 Dec 2016.
    • 21 Sep 2016 Status changed from recruiting to active, no longer recruiting.
    • 22 Apr 2016 According to N&N Pharmaceuticals media release, these trials will be conducted in at Georgetown University Hospital, Division of Infectious Diseases and Dr. Princy Kumar will serve as Principal Clinician during this period.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top